Takuya Tada

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 26

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

bioRxiv : the preprint server for biology

Science advances

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Takuya Tada, Thomas D Norton, Rebecca Leibowitz, Nathaniel Roy Landau
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models. Journal for immunotherapy of cancer 12 (4) (2024)
Takuya Tada, Thomas D Norton, Rebecca Leibowitz, Nathaniel Roy Landau
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models. Journal for immunotherapy of cancer 12 (4) (2024)
Takuya Tada, Yanzhao Zhang, Dechuan Kong, Michiko Tanaka, Weitong Yao, Masanori Kameoka, Takamasa Ueno, Hideaki Fujita, Kenzo Tokunaga
Further Characterization of the Antiviral Transmembrane Protein MARCH8. Cells 13 (8) (2024)
Takuya Tada, Thomas D Norton, Rebecca Leibowitz, Nathaniel Roy Landau
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models. Journal for immunotherapy of cancer 12 (4) (2024)
Takuya Tada, Yanzhao Zhang, Dechuan Kong, Michiko Tanaka, Weitong Yao, Masanori Kameoka, Takamasa Ueno, Hideaki Fujita, Kenzo Tokunaga
Further Characterization of the Antiviral Transmembrane Protein MARCH8. Cells 13 (8) (2024)
Takuya Tada, Yanzhao Zhang, Dechuan Kong, Michiko Tanaka, Weitong Yao, Masanori Kameoka, Takamasa Ueno, Hideaki Fujita, Kenzo Tokunaga
Further Characterization of the Antiviral Transmembrane Protein MARCH8. Cells 13 (8) (2024)
Takuya Tada, Yanzhao Zhang, Dechuan Kong, Michiko Tanaka, Weitong Yao, Masanori Kameoka, Takamasa Ueno, Hideaki Fujita, Kenzo Tokunaga
Further Characterization of the Antiviral Transmembrane Protein MARCH8. Cells 13 (8) (2024)
Takuya Tada, Belinda M Dcosta, Hao Zhou, Nathaniel Roy Landau
Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor Decoy. bioRxiv : the preprint server for biology (2023)
Takuya Tada, Belinda M Dcosta, Hao Zhou, Nathaniel Roy Landau
Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor Decoy. bioRxiv : the preprint server for biology (2023)
Takuya Tada, Belinda M Dcosta, Hao Zhou, Nathaniel Roy Landau
Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor Decoy. bioRxiv : the preprint server for biology (2023)
Takuya Tada, Belinda M Dcosta, Julia Minnee, Nathaniel Roy Landau
Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection. bioRxiv : the preprint server for biology (2023)
Takuya Tada, Julia Minnee, Nathaniel Roy Landau
Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model. Proceedings of the National Academy of Sciences of the United States of America 120 (23) (2023)
Hao Zhou, Takuya Tada, Belinda M Dcosta, Nathaniel Roy Landau
Neutralization of SARS-CoV-2 Omicron BA.2 by Therapeutic Monoclonal Antibodies. bioRxiv : the preprint server for biology (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Yanzhao Zhang, Seiya Ozono, Takuya Tada, Minoru Tobiume, Masanori Kameoka, Satoshi Kishigami, Hideaki Fujita, Kenzo Tokunaga
MARCH8 Targets Cytoplasmic Lysine Residues of Various Viral Envelope Glycoproteins. Microbiology spectrum 10 (1) (2022)
Hao Zhou, Belinda M Dcosta, Nathaniel R Landau, Takuya Tada
Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies. Viruses 14 (6) (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Hao Zhou, Belinda M Dcosta, Marie I Samanovic, Mark J Mulligan, Nathaniel Roy Landau, Takuya Tada
B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies. bioRxiv : the preprint server for biology (2021)
Takuya Tada, Hao Zhou, Marie I Samanovic, Belinda M Dcosta, Amber Cornelius, Mark J Mulligan, Nathaniel Roy Landau
Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants. bioRxiv : the preprint server for biology (2021)
Takuya Tada, Belinda M Dcosta, Marie Samanovic-Golden, Ramin Sedaghat Herati, Amber Cornelius, Mark J Mulligan, Nathaniel R Landau
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies. bioRxiv : the preprint server for biology (2021)
Takuya Tada, Yanzhao Zhang, Hideaki Fujita, Kenzo Tokunaga
MARCH8: the tie that binds to viruses. The FEBS journal (2021)
Takuya Tada, Belinda M Dcosta, Hao Zhou, Ada Vaill, Wes Kazmierski, Nathaniel R Landau
Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies. bioRxiv : the preprint server for biology (2021)